Primoris Services Corporation spent the past month rewriting expectations. The stock gained 37% over 30 days, closed at $202.92 on May 5, and jumped another 9.4% that session — only for Q1 2026 results, released after the close that evening, to snap the run hard on May 6. The week's defining tension is simple: the price had already priced in a strong quarter. The numbers didn't co-operate.
The move into results was historic by this stock's standards. A 20% weekly gain, capped by the single-session surge the day of the release, reflected genuine excitement: UBS raised its target to $212 just two days before the print, and options positioning was unusually tilted toward calls. The put/call ratio came in at 0.33 — slightly below its 20-day average and a fraction of the 52-week high of 1.73 hit when the stock was under pressure earlier in the year. That lopsided call exposure left limited downside cushion when the print missed.
The lending market, by contrast, never believed the rally as fully as the options market did. Short interest has been quietly edging higher — up roughly 3% over the past week to 5.6% of the free float — a level that has sat in a tight band between 5.2% and 5.8% for the past six weeks. The borrow cost of 0.41% is low and has actually eased 9% on the week, suggesting no squeeze dynamics and no panic covering. Availability in the borrow pool remains ample, with lend utilization at roughly 12% — well below the 52-week peak of 19.6% — meaning there is no friction for anyone who wants to add a short position after today's selloff. The modest short score of 44.6, which has crept up only gradually through April and into May, points to measured rather than aggressive bearish positioning.
The Street was broadly constructive into the print, and recent analyst moves reflected that. UBS maintained its Buy rating and moved the target from $176 to $212 on May 4 — a meaningful lift just ahead of the release. Guggenheim had already pushed its Buy target to $195 in late April. JP Morgan sits at Neutral with a $171 target — meaningfully below where the stock had been trading — which now looks more prescient. The mean analyst price target across the coverage universe is $179, a level the stock had already well exceeded before the earnings reaction. With the stock reportedly falling more than 45% from recent highs on the May 6 session, that consensus target re-enters the frame as a plausible anchor. The bull case centred on Primoris's Energy segment growth, the PayneCrest acquisition providing data centre exposure, and margin progression over volume. The bear case flagged a 15x EBITDA multiple and execution risk — a concern that, if guidance disappointed, was always going to be punished.
Two institutional moves stand out from the ownership data. BlackRock added 3.55 million shares in the latest reported period, lifting its stake to 15.3% — the largest holder by some distance. First Trust Advisors added 1.44 million shares, taking its position to 6.3%. Both additions came before the post-earnings move, so the mark-to-market impact is material. Wellington Management and State Street also added meaningfully in the quarter. Against that, insiders were net sellers: the CFO sold just over 21,000 shares in late February at $150.72, the Chief Legal Officer sold 30,780 shares at the same price, and the COO trimmed a small position in early April at $143. The combined 90-day net figure shows an award-adjusted net position that moved modestly positive in aggregate, but the executive-level sales at prices well below the subsequent peak tell their own story.
The Q1 print has reset the clock. With no next earnings date yet confirmed, the near-term question is how far analysts revise their targets in the coming days and whether the institutional buying that drove BlackRock and First Trust's recent additions holds, fades, or accelerates at the new, lower price.
See the live data behind this article on ORTEX.
Open PRIM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
